Tacrolimus-PEG conjugates

他克莫司-聚乙二醇缀合物

Report date: 2026/03/06 20:02:51
NME

Base Information

Drug NameTacrolimus-PEG conjugates
Drug Alias NameKI-102
ClassificationSmall molecules > Heterocyclic drugsSmall molecules > Molecular Glue
Mechanisms of ActionCalcineurin inhibitorsCytokines inhibitorsImmunosuppressants +[5] 
TargetsCalcineurinFK506-binding protein 1ACytokines +[4] 
Therapy Area/IndicationsDiabetes Mellitus, Type 1Lupus Erythematosus, Systemic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesChosun UniversityChungbuk National University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesChungbuk National UniversityChosun University
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 1Lupus Erythematosus, Systemic

Other Information

ATC CodeN/A
Related LinksN/A